GSK Pharma Board Meeting for Q1 FY27 Results

Meeting Details

• A meeting of the Board of Directors will be held on Monday, 3rd August 2026.
• The primary agenda is to consider, approve and take on record the Un-audited financial results for the first quarter ended 30th June 2026.

Financial Impact

Financial impact will be determined following the board meeting and subsequent announcement of the quarterly results.